Shorted

Cogstate (CGS) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Positive
just now

Cogstate (ASX:CGS) Draws Attention as Undervalued Stocks Gain Focus

Highlights Cogstates latest financial performance has renewed attention on its valuation despite broader market uncertainty. Energy One and FDC Consolidated Holdings also feature among companies trading below estimated intrinsic value. Rising geopolitical tensions and higher oil prices continue to shape sentiment across Australian equities. Australia's share market is expected to open on a cautious note after weaker leads from Wall Street and a surge in oil prices driven by escalating Mi...

Continue reading
Kalkine
Positive
just now

Could Cogstate (ASX:CGS) Build More Momentum From Its Contract Surge?

Highlights Cogstate has reported stronger annual revenue and improved earnings from continuing operations. A sharp rise in new contracts has strengthened forward visibility across the companys clinical trial business. Margin expansion supports the case for operating leverage, although some benefits were helped by non-recurring factors. Cogstates exposure to central nervous system trials, AI-enabled tools and channel partnerships remains central to its growth story. Contract timing, concentration...

Continue reading
Kalkine
Neutral
just now

Cogstate (ASX:CGS): Healthcare Technology Momentum Keeps This Small-Cap in Focus

Highlights Cogstate continues attracting attention following strong earnings growth and a debt-free balance sheet. Digital cognitive assessment remains an expanding area within global healthcare and clinical research. Clinical trial activity and recurring customer demand continue shaping the company's long-term growth profile. Cogstate Ltd (ASX:CGS), an Australian healthcare technology company specialising in digital cognitive assessment, has attracted renewed...

Continue reading
Kalkine
Neutral
just now

Could CGS (ASX:CGS) Be the Penny Stock Turning Heads This Week?

Highlights Cogstate has attracted attention after delivering strong earnings momentum and securing fresh healthcare-related contracts. Verbrec and Smart Parking are among other profitable small-cap names drawing interest across the market. Strong earnings, healthy balance sheets and genuine commercial activity continue to separate quality penny stocks from speculative peers. Cogstate is leading attention among ASX penny stocks as profitability, earnings momentum and healthcare sector opportun...

Continue reading
Kalkine
Neutral
just now

Why Are Cogstate (ASX:CGS) and Smart Parking (ASX:SPZ) Leading ASX Penny Stocks?

Highlights Cogstate (ASX:CGS) draws attention for consistent earnings momentum and clinical data-driven business strength. Smart Parking (ASX:SPZ) stands out for scalable parking technology solutions and disciplined balance sheet approach. ASX penny stocks shift focus toward quality small caps within broader ASX 300 sentiment trends. ASX penny stocks are gaining renewed attention as investors shift toward quality small caps like Cogstate and Smart Parking, focusing on healthcare innovat...

Continue reading
Kalkine
Positive
just now

Bell Potter Backs Cogstate as Healthcare Tech Growth Gains Momentum

Highlights Cogstate continues expanding its presence in neuroscience-focused clinical trials. Growing demand from biopharma customers and strategic partnerships are supporting business momentum. New opportunities in sleep disorders and psychiatry are helping diversify revenue sources. Cogstate continues building momentum through healthcare technology innovation, strategic partnerships and expanding opportunities across clinical research markets. Cogstate (ASX:CGS) has attracted renewed market...

Continue reading